Federal contract award
75N92024P00245
[24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 622110 — General Medical and Surgical Hospitals |
| PSC | Q301 — Reference Laboratory Testing |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $25.0K |
| Current contract value | $25.0K |
| Potential contract value / ceiling | $25.0K |
| Start date | Jul 11, 2024 |
| Current end date | Jan 23, 2026 |
| Potential end date | Mar 24, 2026 |
| Latest award activity | Jan 23, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 23, 2026 | P00002 | $12.6K | [24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P |
| Sep 10, 2024 | P00001 | $-12.4K | [24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P |
| Aug 1, 2024 | 0 | $24.7K | [24-014184] THE LAB REQUIRES MYELOID MALIGNANCY SEQUENCING PANEL IN ORDER TO THIS TESTING IS REQUIRED TO MAKE CLINICAL DECISIONS FOR PATIENTS SEEN IN OUR CLINIC, RELATES TO CHOICE OF BONE MARROW TRANSPLANT DONOR OR TREATMENT WITH IMMUNOSUPPRESSION. P |
Research next steps
- Verify whether remaining options may extend performance beyond the current end date.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.